ReviewFrontiers in psychiatry2025
How factors of the therapeutic alliance interact with oxytocin neurotransmission in psychotherapy.
Review in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oxytocin (OT) neurotransmission has emerged as a promising target for alleviating psychiatric symptoms associated with depression, stress, and fear. This mini-review focuses on the therapeutic alliance, highlighting five core components: (1) attachment, (2) empathy, (3) social synchrony, (4) trust and cooperation, and (5) social support. We explore how these factors both influence and are modulated by the oxytocinergic system. Based on current empirical evidence, we propose a conceptual framework in which OT-mediated mechanisms dynamically and reciprocally strengthen the therapeutic alliance. We postulate that activation of the OT system by one or more of these components may synergistically enhance all alliance factors, creating a self-reinforcing cycle with potential therapeutic benefits. Finally, we discuss the clinical implications of this model and identify key avenues for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.